Recent advances in the understandings of taste perception have underscored the challenges posed by artificial sweeteners, specifically the notorious aftertaste…
In a groundbreaking advancement poised to revolutionize the diagnosis of mitochondrial diseases, researchers have developed a noninvasive method to assess…
Kaken Pharmaceutical is paying $16 million upfront for the Japanese rights to Astria Therapeutics’ phase 3-stage hereditary angioedema (HAE) drug. Astria…